Skip to main content
Erschienen in: Cardiovascular Ultrasound 1/2014

Open Access 01.12.2014 | How I do it article

Two and three dimensional echocardiography for pre-operative assessment of mitral valve regurgitation

verfasst von: Nishath Quader, Vera H Rigolin

Erschienen in: Cardiovascular Ultrasound | Ausgabe 1/2014

Abstract

Mitral regurgitation may develop when the leaflets or any other portion of the apparatus becomes abnormal. As the repair techniques for mitral valve disease evolved, so has the need for detailed and accurate imaging of the mitral valve prior to surgery in order to better define the mechanism of valve dysfunction and the severity of regurgitation. In patients with significant mitral valve disease who require surgical intervention, multiplane transesophageal echocardiogram (TEE) is invaluable for surgical planning. However, a comprehensive TEE in a patient with complex mitral valve disease requires great experience and skill. There is evidence to suggest that 3D echocardiography can overcome some of the limitations of 2D multiplane TEE and thus is crucial in evaluation of patients undergoing mitral valve surgery. In the following sections, we review some of the crucial 2D and 3D echo images necessary for evaluation of MR based on the Carpentier classification.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1476-7120-12-42) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

NQ carried out image acquisition, image processing, and writing the manuscript. VR helped edit and acquire the images. In addition, VR also helped edit the manuscript. Both authors have read and approved the final manuscript.
Abkürzungen
2D
Two dimensional
TEE
Transesophageal echocardiogram
3D
Three dimensional
MR
Mitral regurgitation
LV
Left ventricular
MPR
Multiplanar reconstruction
MVQ
Mitral valve quantification.

Introduction

The mitral valve apparatus is a complex structure made of the annulus, the leaflets, the chordae, the papillary muscles, and the left ventricular wall [1]. Mitral regurgitation may develop when the leaflets or any other portion of the apparatus becomes abnormal. The mitral valve apparatus may also become dysfunctional when the left ventricle dilates and the papillary muscles are displaced. As the repair techniques for mitral valve disease evolved, so has the need for detailed and accurate imaging of the mitral valve prior to surgery in order to better define the mechanism of valve dysfunction and the severity of regurgitation.
In patients with significant mitral valve disease who require surgical intervention, multiplane transesophageal echocardiogram (TEE) is invaluable for surgical planning. TEE can identify the mechanism of valve pathology and the specific area on the valve causing the malfunction. However, a comprehensive TEE in a patient with complex mitral valve disease requires great experience and skill [24], (Figure 1). Even in experienced hands, using multiplane 2D TEE alone can sometimes lead to misinterpretation of scallops. There is evidence to suggest that 3D echocardiography can overcome some of the limitations of 2D multiplane TEE and thus is crucial in evaluation of patients undergoing mitral valve surgery [57]. In addition, 3D TEE unifies the language used by the echocardiographer to communicate mitral valve pathology to the surgeon by providing an en face (surgeon’s view) of the mitral valve [8].
Mitral valve leaflet anatomy has been described by Carpentier [9] as being divided into six scallops: three that form the anterior leaflet and three that form the posterior leaflet (Figure 2). In addition, Carpentier classified the etiology of mitral valve regurgitation into Type 1-normal leaflet motion, Type II: leaflet prolapse, Type III-restricted leaflet motion. The echocardiographic must be familiar with this nomenclature as part of the preoperative assessment of mitral valve.
The following sections highlight some crucial steps that must be undertaken by the echocardiographer to accurately image the mitral valve. This includes both 2D and 3D assessment of the valve. Of note, the iE33 xMATRIX Echocardiography System (Phillips Healthcare, MA) was utilized for image acquisitions in this paper. Multiple other ultrasound companies also manufacture 3D echo systems. Image acquisition in other systems may vary slightly but the anatomic concepts are similar.

General concepts about 3D echocardiography

The mitral valve is usually beautifully seen using 3D TEE. However, in order to obtain the best images, it is important to understand the basic concepts about image acquisition using this technology. There are three basic modes of image acquisition: Real-time 3D, 3D zoom and full volume acquisition. Each is a tradeoff between sector width, frame rate and spatial resolution.Real-time 3D imaging provides an easy view of the mitral valve with a high frame rate but at the expense of a very narrow sector width (Figure 3). This type of imaging is useful for a quick look at small structures in a limited viewing plane. The second type of image acquisition is called the 3D zoom mode. In this case, the entire mitral valve data set can be acquired in one beat (Figure 4). This mode is useful when there are arrhythmias or a noisy ECG. The disadvantage, however, is the low frame rate and lower spatial resolution. Finally, there is the full volume acquisition mode. In this modality, multiple 3D volumes are acquired over multiple beats. The volumes are then “stitched” together in order to form the complete image. Since multiple volumes are used to create the image, both temporal (frame rate) and spatial resolution is improved (Figure 5). The echocardiographer can choose the number of beats to acquire for each full volume acquisition (usually 1–7 beats). The more beats that are used to form the image, the higher are the frame rate and image quality (Figure 6). However, this type of acquisition requires a stable ECG with a regular rhythm and no movement on the part of the patient or the echocardiographer. If the volumes cannot be properly aligned, stitch artifacts are seen in the final image (Figure 7). Color Doppler images are most often acquired using a full volume acquisition. Recently, a new mode called a “high volume rate (HVR)” mode has been developed. In this modality, the acquisition can be made in one beat with a preserved frame rate. However, the trade-off is in the spatial resolution. Thus, this mode is useful for color Doppler acquisition where frame rate and the ease of a 1 beat acquisition are the priorities. In this case, image quality is less important.

Preoperative assessment of Type I mitral regurgitation

Carpentier classification Type I mitral regurgitation (MR) is due to a perforated leaflet or incomplete mitral leaflet closure due to annular dilation. In the case of annular dilatation, the leaflets and the subvalvular apparatus are usually normal in morphology.The first step in evaluating for type I MR involves multiplane 2D TEE. One must recognize that one of the etiologies of the MR in this group is when the leaflets are usually normal but do not coapt as a result of annular dilatation (Figure 8). The malcoaption of the leaflets results in severe mitral regurgitation.
In addition to measuring the mitral annulus to establish that the MR is indeed due to annular dilation, the echocardiographer should also measure the tricuspid annulus (Figure 8). There have been several studies demonstrating that the pre-surgical tricuspid annulus measurement predicts residual functional tricuspid regurgitation post mitral valve surgery [10, 11]. The echocardiographer should determine the amount of tricuspid regurgitation to determine if a concomitant tricuspid annuloplasty ring is warranted at the time of mitral valve surgery. Lastly, one should also determine pulmonary artery systolic pressures since this may help in the assessment of the right ventricle post mitral valve surgery.
In addition to recognizing that there is type I MR present, the echocardiographer should also make an attempt to quantify the severity of MR according to established guidelines [1215]. Figure 9 demonstrates the parameters needed to quantify mitral regurgitation. The echocardiographic should be familiar with the valvular heart disease guidelines and be cognizant of the qualitative and quantitative signs of severe MR [1215].Lastly, 3D TEE is very helpful in the evaluation of type I MR. Some echocardiographers may choose to perform 3D TEE before even the 2D portion since this provides and enface view of the mitral valve and can be acquired relatively quickly. 3D TEE with color can be used to establish the origin of the MR jet (Figure 10). In addition, 3D TEE mitral valve quantification (MVQ) function can be used to assess the mitral annulus to confirm the size and shape of the annulus (Figure 11).

Preoperative assessment of Type II mitral regurgitation

This group consists of patients with mitral valve prolapse or flail leaflet either due to Barlow’s disease or due to fibroelastic deficiency. It is important to differentiate between these two entities since this may affect surgical management. Once the pathology has been identified as mitral valve prolapse, the echocardiographer must then accurately determine the scallops involved 2D TEE can identify the diseased scallops by performing a detailed, multiplane assessment [16]. The echocardiographer should also measure the coaptation-septum distance as this is one of the determinants of postoperative systolic anterior motion of mitral valve [17]; (Figure 12). Also, the left ventricular (LV) dimensions and estimated ejection fraction should be determined. The LV chamber dimensions are measured from the midesophageal and gastric two chamber views [18]; (Figure 13).3D TEE can be acquired in a few simple steps (Figure 14). This can significantly help in the diagnosis by complementing the images obtained on 2D imaging. Once the 3D image has been acquired, a few simple post-processing steps as highlighted in Figure 14 can be performed so that the image can be oriented properly in the surgeon’s view. 3D Color Doppler imaging can then be performed to localize the origin of the regurgitant jet (Figure 15).

Preoperative assessment of Type III mitral regurgitation

Type 3A MR

This type of mitral regurgitation is caused by restricted leaflet motion in both systole and diastole. The classic example of this type of lesion is rheumatic disease. The typical rheumatic mitral valve is usually thickened. The anterior leaflet demonstrates a hockey stick deformity in diastole and the posterior leaflet is restricted in both systole and diastole (Figure 16). The restricted systolic motion of the posterior leaflet results in mitral regurgitation.3D TEE can be helpful here again to identify the classic “fish mouth” appearance of the mitral valve and to identify the extent of commissural fusion (Figure 17). One may utilize either the 3D zoom mode or a 3D full volume if the patient’s rhythm is regular. In addition, the mitral valve can be viewed from the LV side to fully appreciate the pathology (Figure 18).

Type 3B MR

This entity is classified as restricted leaflet motion in systole alone. Type 3B MR is often seen in ischemic MR where there is LV dilatation, dysfunction of the inferolateral wall and posterior papillary muscle displacement resulting in leaflet tethering and restricted motion of the posterior leaflet. Due to the abnormal coaptation of the anterior and posterior leaflets, the jet of MR is in the direction of the affected leaflet (Figure 19). In addition, the tenting height (coaptation depth) and tenting area should be measured (Figure 19, Panel C). The echocardiographer should also measure the vena contracta and the effective regurgitant orifice area (EROA). The vena contracta is measured as the narrowest portion of the jet as it regurgitates back into the left atrium [13, 14]. Figure 20 demonstrates how the vena contracta is measured. In this example the vena contracta measured 0.5 cm consistent with moderate MR. However the MR is clearly severe by visual estimation of the MR color Doppler. This is when 3D TEE and multiplanar reconstruction (MPR) can be utilized to assess the true EROA. In this 3D function, the echocardiographer can use the orthogonal planes of the regurgitant jet to obtain an en-face view of the vena contracta (Figure 20, Panel B and C) and thus can trace the EROA. Note in Figure 20C, the EROA is demonstrated along with the vena contracta. In this example the EROA was in the severe range despite what the vena contracta showed.

Conclusion

Mitral regurgitation is a complex yet common valvular disease, which requires careful assessment to elucidate the etiology. The echocardiographer should have the knowledge and expertise to assess mitral valve disease and convey the findings to the surgeon preoperatively. 3D echo is complimentary to 2D multiple TEE and should be utilized as part of mitral valve preoperative assessment. Lastly, every attempt should be made to quantitate the amount of MR regardless of the visual impression.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

NQ carried out image acquisition, image processing, and writing the manuscript. VR helped edit and acquire the images. In addition, VR also helped edit the manuscript. Both authors have read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Otto CM: Evaluation and management of chronic mitral regurgitation. N Engl J Med. 2001, 345: 740-10.1056/NEJMcp003331.CrossRefPubMed Otto CM: Evaluation and management of chronic mitral regurgitation. N Engl J Med. 2001, 345: 740-10.1056/NEJMcp003331.CrossRefPubMed
2.
Zurück zum Zitat Foster GP, Isselbacher EM, Rose GA: Accurate localization of mitral regurgitation defects using multiplane transesophageal echocardiography. Ann Thorac Surg. 1998, 65: 025e31-CrossRef Foster GP, Isselbacher EM, Rose GA: Accurate localization of mitral regurgitation defects using multiplane transesophageal echocardiography. Ann Thorac Surg. 1998, 65: 025e31-CrossRef
3.
Zurück zum Zitat Enriquez-Sarano M, Freeman WK, Tribouilloy CM, Orszulak TA, Khandheria BK, Seward JB, Bailey KR, Tajik AJ: Functional anatomy of mitral regurgitation: accuracy and outcome of transesophageal echocardiography. J Am Coll Cardiol. 1999, 34: 1129e36- Enriquez-Sarano M, Freeman WK, Tribouilloy CM, Orszulak TA, Khandheria BK, Seward JB, Bailey KR, Tajik AJ: Functional anatomy of mitral regurgitation: accuracy and outcome of transesophageal echocardiography. J Am Coll Cardiol. 1999, 34: 1129e36-
4.
Zurück zum Zitat Grewal K, Malkowski M, Kramer C, Dianzumba S, Reichek N: Multiplane transoesophageal echocardiographic identification of the involved scallop in patients with flail mitral valve leaflet: intraoperative correlation. J Am Soc Echocardiogr. 1998, 11: 966e71-CrossRef Grewal K, Malkowski M, Kramer C, Dianzumba S, Reichek N: Multiplane transoesophageal echocardiographic identification of the involved scallop in patients with flail mitral valve leaflet: intraoperative correlation. J Am Soc Echocardiogr. 1998, 11: 966e71-CrossRef
5.
Zurück zum Zitat Chauvel C, Bogino E, Clerc P, Fernandez G, Vernhet JC, Becat A, Dehant P: Usefulness of three-dimensional echocardiography for the evaluation of mitral valve prolapse: an intraoperative study. J Heart Valve Dis. 2000, 9: 341e9- Chauvel C, Bogino E, Clerc P, Fernandez G, Vernhet JC, Becat A, Dehant P: Usefulness of three-dimensional echocardiography for the evaluation of mitral valve prolapse: an intraoperative study. J Heart Valve Dis. 2000, 9: 341e9-
6.
Zurück zum Zitat Hozumi T, Yoshikawa J, Yoshida K, Akasaka T, Takagi T, Yamamuro A: Assessment of flail mitral leaflets by dynamic three-dimensional echocardiographic imaging. Am J Cardiol. 1997, 79: 223e5-CrossRef Hozumi T, Yoshikawa J, Yoshida K, Akasaka T, Takagi T, Yamamuro A: Assessment of flail mitral leaflets by dynamic three-dimensional echocardiographic imaging. Am J Cardiol. 1997, 79: 223e5-CrossRef
7.
Zurück zum Zitat Salustri A, Becker AE, van Herwerden L, Vletter WB, Ten Cate FJ, Roelandt JR: Three-dimensional echocardiography of normal and pathologic mitral valve: a comparison with two-dimensional transoesophageal echocardiography. J Am Coll Cardiol. 1996, 27: 1502e10- Salustri A, Becker AE, van Herwerden L, Vletter WB, Ten Cate FJ, Roelandt JR: Three-dimensional echocardiography of normal and pathologic mitral valve: a comparison with two-dimensional transoesophageal echocardiography. J Am Coll Cardiol. 1996, 27: 1502e10-
8.
Zurück zum Zitat Tsang W, Lang RM: Is 3-dimensional echocardiography essential for intraoperative assessment of mitral regurgitation?. Circulation. 2013, 128: 643-10.1161/CIRCULATIONAHA.112.120501.CrossRefPubMed Tsang W, Lang RM: Is 3-dimensional echocardiography essential for intraoperative assessment of mitral regurgitation?. Circulation. 2013, 128: 643-10.1161/CIRCULATIONAHA.112.120501.CrossRefPubMed
9.
Zurück zum Zitat Carpentier AF, Lessana A, Relland JYM, Belli E, Mihaileanu S, Berebi AJ, Palsky E, Loulmet DF: The physio-ring: an advanced concept in mitral valve annuloplasty. Ann Thorac Surg. 1995, 60 (5): 1177-1185. 10.1016/0003-4975(95)00753-8.CrossRefPubMed Carpentier AF, Lessana A, Relland JYM, Belli E, Mihaileanu S, Berebi AJ, Palsky E, Loulmet DF: The physio-ring: an advanced concept in mitral valve annuloplasty. Ann Thorac Surg. 1995, 60 (5): 1177-1185. 10.1016/0003-4975(95)00753-8.CrossRefPubMed
10.
Zurück zum Zitat Colombo T, Russo C, Cilibert GR, Lanfranconi M, Bruschi G, Agati S, Vitali E: Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair. Cardiovasc Surg. 2001, 9 (4): 369-377. 10.1016/S0967-2109(00)00147-2.CrossRefPubMed Colombo T, Russo C, Cilibert GR, Lanfranconi M, Bruschi G, Agati S, Vitali E: Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair. Cardiovasc Surg. 2001, 9 (4): 369-377. 10.1016/S0967-2109(00)00147-2.CrossRefPubMed
11.
Zurück zum Zitat Matsunaga A, Duran CMG: Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation. 2005, 112: 453-457. 10.1161/CIRCULATIONAHA.105.553289.CrossRef Matsunaga A, Duran CMG: Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation. 2005, 112: 453-457. 10.1161/CIRCULATIONAHA.105.553289.CrossRef
12.
Zurück zum Zitat Vahanian A, Ottavio A, Andreotti F, Antunes MJ, Baron-Esquivia G, Baumgartner H, Borger MA, Carrel TP, DeBonis M, Evangelista A, Falk V, Iung B, Lancelloti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Oppell U, Windecker S, Zamorano JL, Zembala M: Guidelines of the management of valvular heart disease. Eur Heart J. 2012, 33: 2451-2496.CrossRefPubMed Vahanian A, Ottavio A, Andreotti F, Antunes MJ, Baron-Esquivia G, Baumgartner H, Borger MA, Carrel TP, DeBonis M, Evangelista A, Falk V, Iung B, Lancelloti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Oppell U, Windecker S, Zamorano JL, Zembala M: Guidelines of the management of valvular heart disease. Eur Heart J. 2012, 33: 2451-2496.CrossRefPubMed
13.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt T, Thomas JD: 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2014, 63 (22): e57-e185. 10.1016/j.jacc.2014.02.536.CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt T, Thomas JD: 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2014, 63 (22): e57-e185. 10.1016/j.jacc.2014.02.536.CrossRefPubMed
14.
Zurück zum Zitat Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ: Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler. J Am Soc Echocardiogr. 2003, 16: 777-802. 10.1016/S0894-7317(03)00335-3.CrossRefPubMed Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ: Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler. J Am Soc Echocardiogr. 2003, 16: 777-802. 10.1016/S0894-7317(03)00335-3.CrossRefPubMed
15.
Zurück zum Zitat Lancelotti P, Tribouilloy C, Hagendorff A, Popesco BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL: Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013, 14: 611-644. 10.1093/ehjci/jet105.CrossRef Lancelotti P, Tribouilloy C, Hagendorff A, Popesco BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL: Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013, 14: 611-644. 10.1093/ehjci/jet105.CrossRef
16.
Zurück zum Zitat Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH: Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013, 26: 921-964. 10.1016/j.echo.2013.07.009.CrossRefPubMed Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH: Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013, 26: 921-964. 10.1016/j.echo.2013.07.009.CrossRefPubMed
17.
Zurück zum Zitat Varghese R, Itagaki S, Anyanwu AC, Trigo P, Fischer G, Adams DH: Predicting systolic anterior motion after mitral valve reconstruction: using intraoperative transesophageal echocardiography to identify those at greatest risk. Eur J Cardiothorac Surg. 2014, 45 (1): 132-137. 10.1093/ejcts/ezt234.CrossRefPubMed Varghese R, Itagaki S, Anyanwu AC, Trigo P, Fischer G, Adams DH: Predicting systolic anterior motion after mitral valve reconstruction: using intraoperative transesophageal echocardiography to identify those at greatest risk. Eur J Cardiothorac Surg. 2014, 45 (1): 132-137. 10.1093/ejcts/ezt234.CrossRefPubMed
18.
Zurück zum Zitat Lang RM, Bierig M, Devereaux RB, Flachskampf FA, Foster E, Pellika PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MJ, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18 (12): 1440-1463. 10.1016/j.echo.2005.10.005.CrossRefPubMed Lang RM, Bierig M, Devereaux RB, Flachskampf FA, Foster E, Pellika PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MJ, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18 (12): 1440-1463. 10.1016/j.echo.2005.10.005.CrossRefPubMed
Metadaten
Titel
Two and three dimensional echocardiography for pre-operative assessment of mitral valve regurgitation
verfasst von
Nishath Quader
Vera H Rigolin
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
Cardiovascular Ultrasound / Ausgabe 1/2014
Elektronische ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-12-42

Weitere Artikel der Ausgabe 1/2014

Cardiovascular Ultrasound 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.